Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

SUPN Stock Forecast, Price Targets, Chart, Dividends & Analysis

Supernus Pharmaceuticals Inc. logo

Supernus Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

32.10
 
USD
  
-0.06
  
(-0.19%)
Previous close: 32.16  Open: 32.04  Bid: 30.95  Ask: 33.32
52 week range    
21.99   
   35.44
Mkt Cap: 1,763 M  Avg Vol (90 Days): 443,949
Peers   
ZGNX / 
UTHR / 
ABT / 
BMY / 
LLY / 
Last updated: Friday 4th October 2024

Stock Rankings

61
MarketXLS Rank
60
Value
61
Technical
63
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABT

0.0196198 B35.7112.23

BMY

0.0471107 B-1754.2

JNJ

0.0307390 B24.94160.5

LLY

0.0059841 B114.68885.55

UTHR

16 B14.91350.07

ZGNX

-626.68
Financials

SUPN Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles-229000.0-200000.0-1 M-7 M-5 M5 M16 M30 M83 M82 M
Basic EPS from continuing operations2.162.411.011.130.02
Basic EPS total0.470.291.841.132.132.162.411.011.130.02
Basic weighted shares outstanding42 M47 M49 M51 M52 M52 M53 M53 M54 M55 M
Cost of sales-6 M-8 M-12 M-15 M-15 M17 M52 M75 M87 M84 M
Depreciation-699000.02 M4 M3 M3 M3 M
Depreciation unreconciled-699000.0-700000.0-1 M-1 M-2 M5 M16 M30 M83 M82 M
DepreciationAndAmortization-699000.0-700000.0-1 M-1 M-2 M5 M16 M30 M83 M82 M
Diluted EPS total0.320.281.761.082.052.12.360.981.040.02
Diluted normalized net income/share2.12.360.981.040.02
Diluted weighted shares outstanding51 M51 M52 M53 M54 M54 M54 M54 M62 M56 M
Earnings from equity interest13 M
EarningsFromEquityInterestNetOfTax13 M
GainOnSaleOfSecurity3 M193000.0448000.076000.0
GeneralAndAdministrativeExpense-2 M-3 M-3 M-3 M-4 M153 M201 M305 M377 M336 M
Gross operating profit116 M139 M203 M287 M394 M376 M468 M505 M580 M524 M
Income before tax20 M15 M50 M101 M140 M147 M169 M73 M61 M3 M
Income taxes-4 M666000.0-41 M43 M29 M34 M42 M20 M32000.01 M
Interest income348000.0-3 M-3 M1 M14 M22 M19 M4 M
InterestExpenseNonOperating5 M1 M543000.0134000.0-14 M18 M24 M23 M3 M1 M
InterestExpenseOperating-3 M-2 M
InterestIncomeOperating5 M1 M543000.0134000.0
MiscOtherSpecialCharges-3 M-2 M-671000.0-295000.0-4 M-1 M-5 M-13 M15 M8 M
Net income from total operations20 M14 M91 M57 M111 M113 M127 M53 M61 M1 M
NetIncomeCommonStockholders20 M14 M91 M57 M111 M113 M127 M53 M61 M1 M
NetIncomeContinuousOperations20 M14 M91 M57 M111 M113 M127 M53 M61 M1 M
NetNonOperatingInterestIncomeExpense-5 M-4 M-4 M1 M28 M21 M16 M9 M1 M-1 M
Normalized income51 M21 M
Operating income24 M21 M54 M100 M144 M149 M174 M86 M46 M-5 M
Operating income before depreciation (EBITDA)28 M18 M54 M109 M145 M170 M211 M129 M151 M89 M
OperatingExpense92 M118 M149 M187 M249 M228 M292 M425 M534 M510 M
Other income net-256000.02 M223000.0219000.04 M1 M7 M6 M-15 M11 M
OtherGandA-2 M-3 M-3 M-3 M-4 M153 M201 M305 M377 M336 M
OtherImpairmentOfCapitalAssets20 M
OtherOperatingExpenses-80000.0-646000.0-662000.0-1 M-1 M-208000.0-1 M-898000.0-32000.0-112000.0
PromotionAndAdvertising-15 M41 M55 M86 M132 M100 M
RentAndLandingFees-2 M-3 M-3 M-3 M-4 M
Research & development expense20 M29 M43 M50 M89 M69 M76 M90 M75 M92 M
ResearchExpense20 M29 M43 M50 M89 M69 M76 M90 M75 M92 M
Revenue per share-229000.0-948000.0-2 M-7 M-17 M5 M16 M30 M83 M82 M
SalariesAndWages-3 M-4 M-6 M-8 M-11 M146400.069500.02 M
Selling Gen & administrative expense72 M89 M106 M138 M160 M153 M201 M305 M377 M336 M
SellingAndMarketingExpense72 M89 M106 M138 M160 M41 M55 M86 M132 M100 M
SellingExpense72 M89 M106 M138 M160 M
Total Income available for interest expense (EBIT)25 M16 M51 M101 M126 M147 M192 M97 M63 M4 M
Total common shares outstanding44 M49 M50 M52 M52 M53 M53 M53 M54 M55 M
Total net income20 M14 M91 M57 M111 M113 M127 M53 M61 M1 M
Total ordinary shares55 M55 M55 M55 M55 M55 M55 M55 M55 M55 M
Total revenues122 M147 M215 M302 M409 M393 M520 M580 M667 M608 M
TotalExpenses86 M110 M137 M172 M234 M244 M345 M500 M622 M594 M
TotalRevenue90 M144 M210 M302 M409 M393 M520 M580 M667 M608 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University